Due: June 10, 2025 The purpose of this notice of funding opportunity (NOFO) is to support research studies of two or more vaccine adjuvants (combination adjuvants) in order to understand the mechanisms by which they Read More
Due: June 9, 2025 More than 25 million Americans suffer from daily chronic pain, a highly debilitating medical condition that is complex and difficult to manage. In recent decades, there has been an overreliance in Read More
Due: June 9, 2025 This Funding Opportunity Announcement (FOA) encourages applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The NIMH seeks teams of researchers working at different levels of Read More
Due: June 6, 2025 The purpose of this Notice of Funding Opportunity (NOFO) is to invite R01 applications to support new high-priority biomedical and behavioral research that will provide scientific data to inform the regulation Read More
Due: June 6, 2025 This FOA provides support using the SBIR cooperative agreement mechanisms for the development of novel extracellular vesicle-based therapeutic platforms for use in regenerative medicine. Both native and engineered EVs have demonstrated Read More
Anticipated Release Date: Q4FY23 The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) is seeking to establish an integrator for evaluating innovative medical countermeasure (MCM) technologies to meet critical unmet Read More
Due: June 13, 2025 In order to modernize the DoD to be a ready and resilient Force, PMS 408 is seeking to build a capability through MTEC that is poised to rapidly advance prototypes related Read More
Anticipated Release Date: TBA The objective of this effort is to deliver a minimum viable predictive model prototype for PTSD and associated stress-related mental disorders among active component Sailors that is functional in DoD analytics Read More
Due: June 6, 2025 The JPEO-CBRND is interested in late-stage development of host-directed therapeutics or repurposing of United States Food and Drug Administration (FDA) licensed therapeutics that are threat-agnostic with the potential for activity across Read More
Due: June 13, 2025 The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) supports the warfighter through medical countermeasure development for biological threats, both known and unknown. Preventative treatments and Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.